Patent · US Expired

Substituted beta-carbolines

US7026331B2 · kind B2 · utility

2Cited by

6References

14Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Olaf Ritzeler · Bad Soden, DE
Alfredo C. Castro · Woburn, US
Louis Grenier · Medford, US
Francois Soucy · Stoneham, US
Wayne W. Hancock · Philadelphia, US
Hormoz Mazdiyasni · Marlborough, US
Vito J. Palombella · Needham, US
Julian Adams · Ridgefield, US

Key dates

Filing date	Jul 28, 2003
Grant date	Apr 11, 2006
Priority date	—
Expiry date	Jul 28, 2023

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The subject matter of the present invention is directed to novel substituted beta-carbolines, and specifically compounds of the formula I, which are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of IκB kinase is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.